Filing Details
- Accession Number:
- 0001209191-18-045430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-03 19:16:36
- Reporting Period:
- 2018-08-01
- Accepted Time:
- 2018-08-03 19:16:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1368148 | Athersys Inc / New | ATHX | Pharmaceutical Preparations (2834) | 204864095 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402605 | K Laura Campbell | 3201 Carnegie Avenue Cleveland OH 44115-2634 | Senior Vice Pres Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-08-01 | 4,700 | $2.00 | 602,944 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-02 | 9,720 | $2.01 | 593,224 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 trading plan that commenced in July 2018. A predefined number of shares may be sold from time-to-time based on predefined price increases over a two-year period.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.02, inclusive.
- Securities beneficially owned are comprised of: (1) 436,272 shares of common stock owned and (2) unvested restricted stock units aggregating 156,952 related to annual awards, which vest quarterly over a three or four-year period from grant date.
Billionaire Hedge Funds
